On May 28, 2020, Quest Diagnostics announced it had received emergency use authorization (EUA) from the FDA for the Quest Diagnostics Self-collection Kit for COVID-19. The self-collection kit is for individuals to self-collect a nasal specimen at home or in a healthcare setting when determined to be appropriate by a healthcare provider.

The self-collection kit allows an individual to swab the front part of the nostril and may be used on children (supervised by an adult) as well as adults. Specimens are shipped overnight via FedEx at room temperature.